These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 26409098)

  • 1. Clinical safety of the ProMRI pacemaker system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.
    Bailey WM; Mazur A; McCotter C; Woodard PK; Rosenthal L; Johnson W; Mela T;
    Heart Rhythm; 2016 Feb; 13(2):464-71. PubMed ID: 26409098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical safety of the ProMRI pacemaker system in patients subjected to head and lower lumbar 1.5-T magnetic resonance imaging scanning conditions.
    Bailey WM; Rosenthal L; Fananapazir L; Gleva M; Mazur A; Rinaldi CA; Kypta A; Merkely B; Woodard PK;
    Heart Rhythm; 2015 Jun; 12(6):1183-91. PubMed ID: 25680307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.
    Awad K; Griffin J; Crawford TC; Lane Cox S; Ferrick K; Mazur A; Pena RE; Lloyd SG; Michalski J; Johnson W; Bailey WM
    Heart Rhythm; 2015 Oct; 12(10):2155-61. PubMed ID: 26049048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical safety of an MRI conditional implantable cardioverter defibrillator system: A prospective Monocenter ICD-Magnetic resonance Imaging feasibility study (MIMI).
    Kypta A; Blessberger H; Hoenig S; Saleh K; Lambert T; Kammler J; Fellner F; Lichtenauer M; Steinwender C
    J Magn Reson Imaging; 2016 Mar; 43(3):574-84. PubMed ID: 26335332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical safety of the ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 3 T: results of the ProMRI 3T ENHANCED Master study.
    Zbinden R; Wollmann C; Brachmann J; Michaelsen J; Steinwender C; Kovoor P; Kelle S; McGavigan AD; Ching CK; Figtree GA; Schmidt J; Timmel T; Lotz J
    Europace; 2019 Nov; 21(11):1678-1685. PubMed ID: 31322701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations.
    Sommer T; Naehle CP; Yang A; Zeijlemaker V; Hackenbroch M; Schmiedel A; Meyer C; Strach K; Skowasch D; Vahlhaus C; Litt H; Schild H
    Circulation; 2006 Sep; 114(12):1285-92. PubMed ID: 16966587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter study of the safety and effects of magnetic resonance imaging in patients with coronary sinus left ventricular pacing leads.
    Sheldon SH; Bunch TJ; Cogert GA; Acker NG; Dalzell CM; Higgins JV; Espinosa RE; Asirvatham SJ; Cha YM; Felmlee JP; Watson RE; Anderson JL; Brooks MH; Osborn JS; Friedman PA
    Heart Rhythm; 2015 Feb; 12(2):345-9. PubMed ID: 25433144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI scanning in patients with new and existing CapSureFix Novus 5076 pacemaker leads: randomized trial results.
    Shenthar J; Milasinovic G; Al Fagih A; Götte M; Engel G; Wolff S; Tse HF; Herr J; Carrithers J; Cerkvenik J; Nähle CP
    Heart Rhythm; 2015 Apr; 12(4):759-65. PubMed ID: 25556038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Safety of Cardiac and Thoracic Magnetic Resonance Imaging in Patients with Cardiac Implantable Electronic Devices.
    Dandamudi S; Collins JD; Carr JC; Mongkolwat P; Rahsepar AA; Tomson TT; Verma N; Arora R; Chicos AB; Kim SS; Lin AC; Passman RS; Knight BP
    Acad Radiol; 2016 Dec; 23(12):1498-1505. PubMed ID: 27717762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Evaluation of Magnetic Resonance Imaging in Patients With a Magnetic Resonance Imaging Conditional Pacemaker System: Results of 4-Year Prospective Follow-Up in 2,629 Patients.
    Williamson BD; Gohn DC; Ramza BM; Singh B; Zhong Y; Li S; Shanahan L;
    JACC Clin Electrophysiol; 2017 Nov; 3(11):1231-1239. PubMed ID: 29759618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker.
    Reddy VY; Exner DV; Cantillon DJ; Doshi R; Bunch TJ; Tomassoni GF; Friedman PA; Estes NA; Ip J; Niazi I; Plunkitt K; Banker R; Porterfield J; Ip JE; Dukkipati SR;
    N Engl J Med; 2015 Sep; 373(12):1125-35. PubMed ID: 26321198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical safety and performance of a MRI conditional pacing system in patients undergoing cardiac MRI.
    Ching CK; Chakraborty RN; Kler TS; Pumprueg S; Ngarmukos T; Chan JYS; Anand S; Yadav R; Sitthisook S; Yim KW; Jaswal RK; Bhargava K
    Pacing Clin Electrophysiol; 2017 Dec; 40(12):1389-1395. PubMed ID: 29090491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A detailed view on pacemaker lead parameters remotely transmitted after magnetic resonance.
    Wollmann CG; Steiner E; Kleinjung F; Mayr H
    Pacing Clin Electrophysiol; 2015 Jun; 38(6):746-57. PubMed ID: 25787901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cumulative effects and clinical safety of repeat magnetic resonance imaging on an MRI-conditional pacemaker system at 1.5 tesla.
    Nguyen TD; Sandberg SA; Durrani AK; Mitchell KW; Keith MD; Gleva MJ; Woodard PK
    Heart Rhythm O2; 2021 Feb; 2(1):73-79. PubMed ID: 34113907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment.
    Wilkoff BL; Bello D; Taborsky M; Vymazal J; Kanal E; Heuer H; Hecking K; Johnson WB; Young W; Ramza B; Akhtar N; Kuepper B; Hunold P; Luechinger R; Puererfellner H; Duru F; Gotte MJ; Sutton R; Sommer T;
    Heart Rhythm; 2011 Jan; 8(1):65-73. PubMed ID: 20933098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary findings on the safety of 1.5 and 3 Tesla magnetic resonance imaging in cardiac pacemaker patients.
    van Dijk VF; Delnoy PPHM; Smit JJJ; Ramdat Misier RA; Elvan A; van Es HW; Rensing BJWM; Raciti G; Boersma LVA
    J Cardiovasc Electrophysiol; 2017 Jul; 28(7):806-810. PubMed ID: 28429537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla.
    Gimbel JR; Bello D; Schmitt M; Merkely B; Schwitter J; Hayes DL; Sommer T; Schloss EJ; Chang Y; Willey S; Kanal E;
    Heart Rhythm; 2013 May; 10(5):685-91. PubMed ID: 23333721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real world MRI experience with nonconditional and conditional cardiac rhythm devices after MagnaSafe.
    Mason S; Osborn JS; Dhar R; Tonkin A; Ethington JD; Le V; Benuzillo J; Lappe DL; Knowlton KU; Bunch TJ; Anderson JL
    J Cardiovasc Electrophysiol; 2017 Dec; 28(12):1468-1474. PubMed ID: 28960745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators.
    Cohen JD; Costa HS; Russo RJ
    Am J Cardiol; 2012 Dec; 110(11):1631-6. PubMed ID: 22921995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices.
    Nazarian S; Hansford R; Rahsepar AA; Weltin V; McVeigh D; Gucuk Ipek E; Kwan A; Berger RD; Calkins H; Lardo AC; Kraut MA; Kamel IR; Zimmerman SL; Halperin HR
    N Engl J Med; 2017 Dec; 377(26):2555-2564. PubMed ID: 29281579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.